Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 26,033 | 0 | 0 | 0 | 0 |
| Gross Profit | 26,033 | N/A | N/A | N/A | N/A |
| Operating Expenses | 48,485 | 69,056 | 119,316 | 99,038 | 30,310 |
| Operating Income | -22,452 | -69,056 | -119,316 | -99,038 | -30,310 |
| Interest Expense | 0 | 0 | 21 | 7 | 443 |
| Other Income | 7,047 | 7,070 | 1,544 | -105,658 | -88,671 |
| Pre-tax Income | -15,405 | -61,986 | -117,793 | -204,703 | -119,424 |
| Income Tax | 223 | 120 | 298 | 266 | N/A |
| Net Income Continuous | -15,628 | -62,106 | -118,091 | -204,969 | -119,424 |
| Net Income | $-15,628 | $-62,106 | $-118,091 | $-204,969 | $-119,424 |
| EPS Basic Total Ops | -0.28 | -1.13 | -2.15 | -3.90 | -4.00 |
| EPS Basic Continuous Ops | -0.28 | -1.13 | -2.15 | -3.93 | -4.02 |
| EPS Diluted Total Ops | -0.28 | -1.13 | -2.15 | -3.90 | -4.00 |
| EPS Diluted Continuous Ops | -0.28 | -1.13 | -2.15 | -3.93 | -4.02 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -1.08 | -2.10 | -3.90 | N/A |
| EBITDA(a) | $-21,792 | $-68,336 | $-118,285 | $-98,398 | $-30,089 |